药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Oxymetazoline
Yellow Fever Vaccine
The risk or severity of infection can be increased when Yellow Fever Vaccine is combined with Hydroxychloroquine.
Oxymetazoline
Bacillus calmette-guerin substrain connaught live antigen
The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Hydroxychloroquine.
Oxymetazoline
Bacillus calmette-guerin substrain tice live antigen
The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Hydroxychloroquine.
Oxymetazoline
Varicella Zoster Vaccine (Live/attenuated)
The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Hydroxychloroquine.
Oxymetazoline
Rubella virus vaccine
The risk or severity of infection can be increased when Rubella virus vaccine is combined with Hydroxychloroquine.
Oxymetazoline
Pitolisant
The serum concentration of Hydroxychloroquine can be decreased when it is combined with Pitolisant.
Oxymetazoline
Delamanid
Hydroxychloroquine may increase the QTc-prolonging activities of Delamanid.
Oxymetazoline
Vemurafenib
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Hydroxychloroquine.
Oxymetazoline
Moderna COVID-19 Vaccine
The therapeutic efficacy of Moderna COVID-19 Vaccine can be decreased when used in combination with Hydroxychloroquine.
Oxymetazoline
Ebola Zaire vaccine (live, attenuated)
The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Hydroxychloroquine.
Oxymetazoline
Modified vaccinia ankara
The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Hydroxychloroquine.
Oxymetazoline
Varicella Zoster Vaccine (Recombinant)
The therapeutic efficacy of Varicella Zoster Vaccine (Recombinant) can be decreased when used in combination with Hydroxychloroquine.
Oxymetazoline
Yersinia pestis 195/p antigen (formaldehyde inactivated)
The therapeutic efficacy of Yersinia pestis 195/p antigen (formaldehyde inactivated) can be decreased when used in combination with Hydroxychloroquine.
Oxymetazoline
Pertussis vaccine
The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Hydroxychloroquine.
Oxymetazoline
Smallpox (Vaccinia) Vaccine, Live
The therapeutic efficacy of Smallpox (Vaccinia) Vaccine, Live can be decreased when used in combination with Hydroxychloroquine.
Oxymetazoline
Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated)
The therapeutic efficacy of Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated) can be decreased when used in combination with Hydroxychloroquine.
Oxymetazoline
Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated)
The therapeutic efficacy of Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated) can be decreased when used in combination with Hydroxychloroquine.
Oxymetazoline
Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen
The therapeutic efficacy of Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen can be decreased when used in combination with Hydroxychloroquine.
Oxymetazoline
Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated)
The therapeutic efficacy of Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) can be decreased when used in combination with Hydroxychloroquine.
Oxymetazoline
Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen
The therapeutic efficacy of Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen can be decreased when used in combination with Hydroxychloroquine.